{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:11:40Z","timestamp":1790475100551,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.09.093","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T17:08:22Z","timestamp":1570727302000},"page":"7123-7131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Capsid containing virus like particle vaccine against Zika virus made from a stable cell line"],"prefix":"10.1016","volume":"37","author":[{"given":"Himanshu","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-9446","authenticated-orcid":false,"given":"Tugba","family":"Mehmetoglu-Gurbuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.093_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/v9050097","article-title":"Historical perspectives on flavivirus research","volume":"9","author":"Holbrook","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.09.093_b0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.09.093_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1605367","article-title":"Zika and the risk of microcephaly","volume":"375","author":"Johansson","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2019.09.093_b0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(17)31368-5","article-title":"Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis","volume":"390","author":"de Oliveira","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.093_b0025","article-title":"Zika virus vaccine development: progress in the face of new challenges","author":"Diamond","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2019.09.093_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006055","article-title":"Zika virus displacement by a chikungunya outbreak in Recife, Brazil","volume":"11","author":"Magalhaes","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2019.09.093_b0035","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.09.093_b0040","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.vaccine.2018.01.056","article-title":"Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells","volume":"36","author":"Basu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.093_b0045","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2019.09.093_b0050","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/s41598-018-35755-z","article-title":"Efficacy of a T cell-biased adenovirus vector as a Zika virus vaccine","volume":"8","author":"Bullard","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.09.093_b0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41598-017-00193-w","article-title":"An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model","volume":"7","author":"Chahal","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.09.093_b0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12250-018-0030-5","article-title":"Zika virus baculovirus-expressed virus-like particles induce neutralizing antibodies in mice","volume":"33","author":"Dai","year":"2018","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2019.09.093_b0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.09.093_b0070","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1038\/s41598-018-29401-x","article-title":"A VSV-based Zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.09.093_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus-like-particle vaccine and reporter assay for Zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.093_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ebiom.2016.09.028","article-title":"Preventative vaccines for Zika virus outbreak: preliminary evaluation","volume":"13","author":"Kim","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2019.09.093_b0090","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.09.093_b0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.09.093_b0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA vaccines protect against Zika Virus infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.09.093_b0105","article-title":"Vaccine mediated protection against Zika Virus-induced congenital disease","volume":"170, 273\u2013283","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.09.093_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/v10110631","article-title":"Recent advances in Zika virus vaccines","volume":"10","author":"Garg","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.09.093_b0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","article-title":"Exploiting virus-like particles as innovative vaccines against emerging viral infections","volume":"55","author":"Jeong","year":"2017","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0125","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1073\/pnas.90.13.6218","article-title":"Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3","volume":"90","author":"Lobigs","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.09.093_b0130","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","article-title":"Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM","volume":"72","author":"Stocks","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0135","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/jvi.69.4.1995-2003.1995","article-title":"Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease","volume":"69","author":"Yamshchikov","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0145","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1099\/vir.0.064121-0","article-title":"Increased expression of capsid protein in trans enhances production of single-round infectious particles by West Nile virus DNA vaccine candidate","volume":"95","author":"Roby","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00009-17","article-title":"Animal models of Zika virus infection, pathogenesis, and immunity","volume":"91","author":"Morrison","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.09.093_b0160","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1128\/JVI.00226-08","article-title":"West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction","volume":"82","author":"Wilson","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0165","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.09.093_b0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2180-13-197","article-title":"Identification of conserved motifs in the West Nile virus envelope essential for particle secretion","volume":"13","author":"Garg","year":"2013","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15d03s31","article-title":"Propagation, quantification, detection, and storage of West Nile virus","volume":"31","author":"Brien","year":"2013","journal-title":"Curr Protocols Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.093_b0180","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.09.093_b0185","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:40Z","timestamp":1759401340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":37,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19313350"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capsid containing virus like particle vaccine against Zika virus made from a stable cell line","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}